Dridi, Haikel
Kushnir, Alexander
Zalk, Ran
Yuan, Qi
Melville, Zephan
Marks, Andrew R. http://orcid.org/0000-0002-4316-5775
Article History
First Online: 8 September 2020
Competing interests
: A.R.M. and Columbia University, USA, own shares in ARMGO Pharma, a biotechnology company developing ryanodine receptor-targeted drugs. The other authors declare no competing interests.